Integrated features within a small footprint
The Agilent 400-DS Dissolution Apparatus for small volume sets the performance standard for drug-release testing of medical devices. It is the first dissolution apparatus built specifically for small-volume dissolution testing of combination drug products that meets all compendial requirements for USP Apparatus 7. The 400-DS complies with 21 CFR Part 11 guidelines and brings an unprecedented level of convenience, throughput, and efficiency to your quality control and R&D operations.
Receive your quote directly from Agilent Technologies for 400-DS Apparatus 7